ACTIVE

INTERNATIONAL DRUG DEVELOPMENT INSTITUTE

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-1,1 M €-101,7 %over 1 year

Revenue11,9 M €-12,5 %over 1 year

Equity21 M €-6,2 %over 1 year

Workforce74,8 ETP-10,5 %over 1 year

Identity

Source · BCE/KBO

INTERNATIONAL DRUG DEVELOPMENT INSTITUTE is a Public limited company incorporated in 1988. Its main activity is: Pre-primary education. Its registered office is in Ottignies-Louvain-la-Neuve. It employs on average 74,8 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0436.264.032
Incorporation: 26/12/1988
Legal form: Public limited company
Registered office: Avenue Provinciale 30
1341 Ottignies-Louvain-la-Neuve · WallonieSee on map
Contributed capital: 75 000,00 €
Latest accounts: 31/12/2025
Average workforce: 74,8 ETP

Activities (NACE)

85141Pre-primary education· main 86901Other human health activities 86910Other human health activities 91110Libraries, archives, museums and other cultural activities 94110Activities of business and employers membership organisations 94110Activities of business and employers membership organisations

Joint committees (3)

Signals

Solid equityLow riskGood liquidityHealthy social debtsHigh revenue

Financials

Source · NBB, 21 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	11,9 M €	-12.5%	13,6 M €	-11.1%	15,3 M €	+3.3%	14,8 M €	+12.2%	13,2 M €
EBITDA	-1,9 M €	-201%	1,9 M €	+757%	-282,7 k €	-170%	405,6 k €	-75.4%	1,6 M €
Operating result	-2 M €	-458%	563,5 k €	+215%	-488,4 k €	-339%	204,4 k €	-85.6%	1,4 M €
Net result	-1,1 M €	-102%	68,1 M €	+74931%	90,7 k €	-87.4%	720 k €	-61.0%	1,8 M €
Balance sheet
Equity	21 M €	-6.2%	22,4 M €	+587%	3,3 M €	-4.7%	3,4 M €	-6.3%	3,6 M €
Total assets	28,5 M €	-62.8%	76,5 M €	+729%	9,2 M €	-1.5%	9,4 M €	-6.8%	10,1 M €
Cash	1,3 M €	-40.6%	2,3 M €	+176%	821 k €	-57.0%	1,9 M €	-19.8%	2,4 M €
Debts	3,4 M €	-93.4%	51,6 M €	+967%	4,8 M €	+21.5%	4 M €	-10.4%	4,4 M €
Other
Workforce	74,8 ETP	-10.5%	83,6 ETP	-15.5%	98,9 ETP	+4.0%	95,1 ETP	-0.8%	95,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 61 ended

Active mandates

Bright Roads

Managing director · since 14 septembre 2023 · until 17 mai 2030 · 0680.861.014

Represented by Marc BUYSE

Active

Amy FURLONG

Chairman of the board of directors · since 01 août 2023 · until 22 octobre 2025

Active

Linda BENEZE

Director · since 01 août 2023 · until 22 octobre 2025

Active

Rob NICHOLS

Director · since 01 août 2023 · until 22 octobre 2025

Active

CLINIMETRICS

Director · since 27 mai 2016 · until 22 octobre 2025 · 0426.756.052

Represented by Marc BUYSE

Active

Ended mandates

Bright Roads

Managing director · since 21 novembre 2024 · until 15 mai 2026 · 0680.861.014

Represented by Damien Tremolet

Ended

Amy FURLONG

Chairman of the board of directors · since 14 septembre 2023 · until 14 septembre 2029

Ended

Bright Roads

Managing director · since 14 septembre 2023 · until 17 mai 2024 · 0680.861.014

Represented by Linda DANIELSON

Ended

Amy FURLONG

Chairman of the board of directors · since 01 août 2023 · until 01 août 2029

Ended

Other companies at this address

Avenue Provinciale 30 1341 Ottignies-Louvain-la-Neuve

Company	CBE no.
Bright Roads● Active	0680.861.014

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	16/06/2026	04/05/2026	14/06/2024	20/06/2023	14/06/2022	18/06/2021
General meeting	18/05/2026	16/05/2025	17/05/2024	22/05/2023	20/05/2022	21/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	18/05/2026	16/06/2026	French	PDF
Full modelCorrection	31/12/2024	16/05/2025	04/05/2026	French	PDF
Full model	31/12/2024	16/05/2025	13/06/2025	French	PDF
Full model	31/12/2023	17/05/2024	14/06/2024	French	PDF
Full model	31/12/2022	22/05/2023	20/06/2023	French	PDF
Full model	31/12/2021	20/05/2022	14/06/2022	French	PDF
Full model	31/12/2020	21/05/2021	18/06/2021	French	PDF
Full model	31/12/2019	15/05/2020	15/06/2020	French	PDF
Full model	31/12/2018	17/05/2019	24/05/2019	French	PDF
Full model	31/12/2017	28/05/2018	25/06/2018	French	PDF
Full model	31/12/2016	19/05/2017	15/06/2017	French	PDF
Full model	31/12/2015	27/05/2016	27/06/2016	French	PDF
Full model	31/12/2014	22/05/2015	22/06/2015	French	PDF
Full model	31/12/2013	16/05/2014	16/06/2014	French	PDF
Full model	31/12/2012	14/06/2013	11/07/2013	French	PDF
Abridged model	31/12/2011	09/06/2012	06/07/2012	French	PDF
Abridged model	31/12/2010	11/06/2011	11/07/2011	French	PDF
Abridged model	31/12/2009	12/06/2010	09/08/2010	French	PDF
Abridged model	31/12/2008	13/06/2009	29/07/2009	French	PDF
Abridged model	31/12/2007	14/06/2008	25/07/2008	French	PDF
Abridged model	31/12/2006	09/05/2007	15/06/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 61 ended

Active mandates

Bright Roads

Managing director · since 14 septembre 2023 · until 17 mai 2030 · 0680.861.014

Represented by Marc BUYSE

Active

Amy FURLONG

Chairman of the board of directors · since 01 août 2023 · until 22 octobre 2025

Active

Linda BENEZE

Director · since 01 août 2023 · until 22 octobre 2025

Active

Rob NICHOLS

Director · since 01 août 2023 · until 22 octobre 2025

Active

CLINIMETRICS

Director · since 27 mai 2016 · until 22 octobre 2025 · 0426.756.052

Represented by Marc BUYSE

Active

Ended mandates

Bright Roads

Managing director · since 21 novembre 2024 · until 15 mai 2026 · 0680.861.014

Represented by Damien Tremolet

Ended

Amy FURLONG

Chairman of the board of directors · since 14 septembre 2023 · until 14 septembre 2029

Ended

Bright Roads

Managing director · since 14 septembre 2023 · until 17 mai 2024 · 0680.861.014

Represented by Linda DANIELSON

Ended

Amy FURLONG

Chairman of the board of directors · since 01 août 2023 · until 01 août 2029

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates30/12/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates30/10/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates30/01/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates08/07/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates31/01/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates20/11/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates05/01/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates19/08/2022
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025-1,1 M €↓
22/10/2025
nominationSA IDDI Group — administrateur unique
22/10/2025
nominationTimothy Davis — délégué à la gestion journalière
2024
Annual accounts 202468,1 M €↑
21/11/2024
nominationDamien Tremolet — représentant permanent d'IDDI Group
17/05/2024
reconductionLinda Danielson — administrateur
17/05/2024
reconductionMarc Buyse — administrateur
17/05/2024
nominationMarie Delacroix — commissaire
2023
Annual accounts 202390,7 k €↓
14/09/2023
nominationLinda Danielson — représentante permanente d'IDDI Group SA au Conseil d'administration
14/09/2023
nominationAmy Furlong — Présidente du Conseil d'administration
01/08/2023
nominationAmy Furlong — administrateur
01/08/2023
nominationLinda Beneze — administrateur
01/08/2023
nominationRob Nichols — administrateur
2022
Annual accounts 2022720 k €↓
16/09/2022
nominationLinda Danielson — Administratrice
20/05/2022
reconductionDamien Tremolet — Administrateur délégué
2021
Annual accounts 20211,8 M €↓
2020
Annual accounts 20204,8 M €↑
2019
Annual accounts 20191,1 M €↓
2018
Annual accounts 20181,2 M €↑
2017
Annual accounts 2017353,4 k €↑
2016
Annual accounts 2016349,4 k €↑
2015
Annual accounts 2015333,4 k €↑
2014
Annual accounts 2014175,3 k €↓
2013
Annual accounts 2013678,4 k €↑
2012
Annual accounts 2012413,7 k €↑
2011
Annual accounts 2011346,3 k €↑
2010
Annual accounts 2010133,4 k €↑
2009
Annual accounts 200933,4 k €↓
2008
Annual accounts 200868,3 k €↑
2007
Annual accounts 200756,2 k €↑
2006
Annual accounts 200635,9 k €
26/12/1988
IncorporationPublic limited company

INTERNATIONAL DRUG DEVELOPMENT INSTITUTE

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline